Results Overall, 991 records were identified, of which 289 were initially removed using the Rayyans automatic technique to detect duplicates
Key Takeaways: Tesamorelin Before and After Visceral fat is the primary target: Tesamorelin is the only peptide with FDA approval for reducing visceral adipose tissue
Secondary outcome measures included change from baseline MHFMS score following 12 versus 6 months treatment, estimates of innervation via maximum ulnar compound muscle action potential (CMAP), dual-energy X-ray absorptiometry (DEXA), evaluation of body composition and bone density, quantitative assessment of SMN mRNA
Diabetes brands and lower doses come in below the figure shown
While research continues, BPC-157 remains one of the most recognised synthetic peptides in the performance-enhancement community
Take collagen, for example